My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
VBI Vaccines (VBIV)
VBIV nasdaq
United States
VBI Vaccines

VBI Vaccines Stock Analysis & Ratings

VBI Vaccines Stock Analysis Overview

Smart Score
Learn more about TipRanks Smart Score
The VBI Vaccines stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart


VBIV Stock Stats

Previous Close$2.86
Bid0 x 0
Ask0 x 0
Today’s Range$2.74 - $2.91
52-Week Range$2.44 - $4.83
Average Volume2.04M
Market Cap$715.31M
P/E Ratio-10.7
Earnings DateFeb 28, 2022
Ex-Dividend DateJul 14, 2015

Company Description

VBI Vaccines

VBI Vaccines, Inc. is a biopharmaceutical company. It engages in the development of eVLP vaccine platform for the design of (e) virus-like-particle vaccines that closely mimic the target virus. The company also involves in the development of thermostable technology that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures. VBI Vaccines was founded on July 25, 2014 and is headquartered in Cambridge, MA.
Jeffrey R. Baxter
222 Third Street, Cambridge, MA, 02142, US


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


What was VBI Vaccines’s price range in the past 12 months?
VBI Vaccines lowest stock price was $2.44 and its highest was $4.83 in the past 12 months.
    What is VBI Vaccines’s market cap?
    VBI Vaccines’s market cap is $715.31M.
      What is VBI Vaccines’s price target?
      Currently, no data Available
      What do analysts say about VBI Vaccines?
      Not enough analysts have published a price target to provide an average price target.
      When is VBI Vaccines’s upcoming earnings report date?
      VBI Vaccines’s upcoming earnings report date is Feb 28, 2022 which is in 92 days.
        How were VBI Vaccines’s earnings last quarter?
        VBI Vaccines released its earnings results on Nov 08, 2021. The company reported -$0.06 earnings per share for the quarter, beating the consensus estimate of -$0.07 by $0.01.
          Is VBI Vaccines overvalued?
          According to Wall Street analysts VBI Vaccines’s price is currently Overvalued.
            Does VBI Vaccines pay dividends?
            VBI Vaccines pays a Notavailable dividend of $4.52 which represents an annual dividend yield of N/A. VBI Vaccines’s last Notavailable dividend payment was on Jul 14, 2015. VBI Vaccines’s upcoming ex-dividend date is Jul 14, 2015
              What is VBI Vaccines’s EPS estimate?
              VBI Vaccines’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does VBI Vaccines have?
              VBI Vaccines has 230,650,000 shares outstanding.
                What happened to VBI Vaccines’s price movement after its last earnings report?
                VBI Vaccines reported an EPS of -$0.06 in its last earnings report, beating expectations of -$0.07. Following the earnings report the stock price went up 1.007%.
                  Which hedge fund is a major shareholder of VBI Vaccines?
                  Among the largest hedge funds holding VBI Vaccines’s share is Perceptive Advisors LLC. It holds VBI Vaccines’s shares valued at 171M.

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis